首页> 外文OA文献 >Down-regulation of miR-30a-5p is Associated with Poor Prognosis and Promotes Chemoresistance of Gemcitabine in Pancreatic Ductal Adenocarcinoma

【2h】

Down-regulation of miR-30a-5p is Associated with Poor Prognosis and Promotes Chemoresistance of Gemcitabine in Pancreatic Ductal Adenocarcinoma

机译：miR-30a-5p的下调与预后差和促进吉西他滨的化学抑制性有关，在胰腺导管腺癌中

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Liangjing Zhou; Shengnan Jia; Guoping Ding; Mingjie Zhang; Weihua Yu; Zhengrong Wu; Liping Cao;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Down-regulation of miR-30a-5p is Associated with Poor Prognosis and Promotes Chemoresistance of Gemcitabine in Pancreatic Ductal Adenocarcinoma [J] . Liangjing Zhou, Shengnan Jia, Guoping Ding, Journal of Cancer . 2019,第21期

机译：miR-30a-5p的下调与预后差和促进吉西他滨的化学抑制性有关，在胰腺导管腺癌中
2. Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma [J] . Zhang Daoxiang, Li Lin, Jiang Hongmei, Clinical cancer research: an official journal of the American Association for Cancer Research . 2017,第7期

机译：构成arak4活化是胰腺导管腺癌的预后和化学性差异很差
3. Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma via Regulating the Cell Cycle [J] . Mugahed Abdullah Hasan Albahde, Piao Zhang, Qiuqiang Zhang, Frontiers in Oncology . 2020,第4期

机译：通过调节细胞周期，Upropaa1c的上调表达预测预后不良，促进胰腺导管腺癌中的血管生成
4. Developing a Novel Biodegradable Nanodrug Platform for Overcoming the Challenges in Treating Pancreatic Ductal Adenocarcinoma (PDAC) [C] . Saadia Nisar, Shannon Handley, Sandhya Clement Conference on Colloidal Nanoparticles for Biomedical Applications . 2021

机译：开发一种新型的可生物降解的纳米树纹平台，用于克服治疗胰腺导管腺癌（PDAC）的挑战
5. ST6Gal-I Mediated Sialylation Promotes Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance [D] . Chakraborty, Asmi. 2019

机译：ST6GAL-I介导的唾液酸化促进胰腺导管腺癌进展和化学性
6. Down-regulation of miR-30a-5p is Associated with Poor Prognosis and Promotes Chemoresistance of Gemcitabine in Pancreatic Ductal Adenocarcinoma [O] . Liangjing Zhou, Shengnan Jia, Guoping Ding, 2019

机译：miR-30a-5p的下调与不良预后相关并促进吉西他滨在胰腺导管腺癌中的化学耐药性。
7. Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma [O] . Daoxiang Zhang, Lin Li, Hongmei Jiang, 2016

机译：构成arak4活化是胰腺导管腺癌的预后和化学性差异很差

Down-regulation of miR-30a-5p is Associated with Poor Prognosis and Promotes Chemoresistance of Gemcitabine in Pancreatic Ductal Adenocarcinoma

著录项

引文网络

相似文献

相关主题

期刊订阅